The expression levels of risk factors IL4I1, SMS, and ADI1 in high-grade gliomas were higher than those in lower‐grade gliomas, while the protein expression levels of protective factor GCLC, MSRB2, MTAP and MPST were exactly the opposite (Fig. S2). The gene discussed is SMS; the disease is central nervous system cancer.